Sale!

KCTD17 Gene DYT26 Myoclonic Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCTD17 Gene DYT26 Myoclonic Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the KCTD17 gene, which have been associated with DYT26 myoclonic dystonia, a rare genetic disorder. This condition is characterized by quick, involuntary muscle contractions (myoclonus) and, in some cases, dystonia, which involves abnormal muscle tone leading to repetitive movements or abnormal postures. The test is particularly crucial for individuals showing symptoms of myoclonic dystonia or those with a family history of the disorder, as it can provide definitive genetic evidence of the condition.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the KCTD17 gene that are known to cause DYT26 myoclonic dystonia. The outcome of this test can aid in the accurate diagnosis of the condition, which is essential for managing symptoms and improving the quality of life for affected individuals.

The cost of the KCTD17 Gene DYT26 Myoclonic Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test and the sophisticated technology and expertise required to accurately identify mutations in the KCTD17 gene. Given the complexity of genetic disorders and the significant impact a definitive diagnosis can have on treatment and management strategies, this test represents a critical step for patients and families dealing with the challenges of DYT26 myoclonic dystonia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCTD17 Gene DYT26 myoclonic Genetic Test

At DNA Labs UAE, we offer the KCTD17 Gene DYT26 myoclonic Genetic Test for individuals suspected of having this rare genetic disorder. This test is designed to analyze the KCTD17 gene, which is associated with DYT26, a condition characterized by myoclonic dystonia.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the KCTD17 Gene DYT26 myoclonic Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by DYT26 and the KCTD17 gene.

Test Details

The KCTD17 gene plays a crucial role in the development of DYT26, a rare genetic disorder characterized by myoclonic dystonia. Myoclonic dystonia causes involuntary muscle contractions and spasms. The KCTD17 gene is responsible for producing a protein involved in the regulation of neurotransmitters, which are chemicals that transmit signals between nerve cells in the brain. Mutations in the KCTD17 gene can disrupt the normal functioning of neurotransmitters, leading to the symptoms associated with DYT26.

Our KCTD17 Gene DYT26 myoclonic Genetic Test utilizes NGS technology, which enables the simultaneous analysis of multiple genes. This comprehensive testing approach allows for the identification of genetic mutations associated with DYT26 and other genetic disorders. The test is typically performed on a blood or saliva sample and can be ordered by a healthcare provider. The results of the test can aid in diagnosis, treatment, and genetic counseling for individuals and their families.

Test Name KCTD17 Gene DYT26 myoclonic Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCTD17 Gene DYT26, myoclonic NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCTD17 Gene DYT26, myoclonic
Test Details

The KCTD17 gene is associated with a rare genetic disorder called DYT26, which is characterized by myoclonic dystonia. Myoclonic dystonia is a movement disorder that causes involuntary muscle contractions and spasms. The KCTD17 gene provides instructions for making a protein that is involved in the regulation of neurotransmitters, which are chemicals that transmit signals between nerve cells in the brain. Mutations in the KCTD17 gene can disrupt the normal functioning of neurotransmitters, leading to the symptoms of DYT26.

NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes at once. This type of testing can provide a comprehensive analysis of an individual’s genetic makeup, allowing for the identification of genetic mutations associated with DYT26 and other genetic disorders. NGS genetic testing is typically performed on a blood or saliva sample and can be ordered by a healthcare provider. The results of the test can help with diagnosis, treatment, and genetic counseling for individuals and their families.